Literature DB >> 21330032

Ankle-brachial index improves the classification of cardiovascular risk: PERART/ARTPER Study.

José M Baena-Díez1, María T Alzamora, Rosa Forés, Guillem Pera, Pere Torán, Marta Sorribes.   

Abstract

INTRODUCTION AND
OBJECTIVES: The sensitivity of cardiovascular risk functions is low because many cardiovascular events occur in low- or intermediate-risk patients. The aim of the present study was to evaluate how the ankle-brachial index (ABI) reclassifies these patients.
METHODS: We conducted a descriptive, transversal, multicenter study (28 centers) of 3171 randomly selected patients aged >49 years. We studied demographic variables, clinical history and cardiovascular risk factors, ABI (defined as pathologic if <0.9) and 10-year cardiovascular risk with the Framingham-Wilson, REGICOR and SCORE equations, dividing risk into three categories: low (Framingham<10%, REGICOR<5% and SCORE<2.5%, intermediate (10-19.9%, 5-9.9% and 2.5-4.9%, respectively) and high (≥20%, ≥10% and ≥5%, respectively). Low- or intermediate-risk patients were reclassified as high-risk if they presented ABI <0.9.
RESULTS: We compared patients with ABI <0.9 and patients with ABI ≥0.9 and found the former were significantly older, more frequently men, had a worse history and more cardiovascular risk factors, and included more high-risk patients than when the classification used Framingham-Wilson (42.7% vs. 18.5%), REGICOR (25.8% vs. 9.3%) and SCORE (42.2% vs. 15.9%) equations. In men, using ABI led to a 5.8% increase in the high-risk category versus Framingham-Wilson, a 19.1% increase versus REGICOR and a 4.4% increase versus SCORE. In women, the increases were 78.6% versus Framingham-Wilson, 151.6% versus REGICOR and 50.0% versus SCORE.
CONCLUSIONS: The ABI reclassifies a substantial proportion of patients towards the high-risk category. This is particularly marked in women and by comparison with REGICOR scores.
Copyright © 2010 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21330032     DOI: 10.1016/j.recesp.2010.10.024

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  6 in total

Review 1.  Peripheral arterial disease and chronic heart failure: a dangerous mix.

Authors:  Sally C Inglis; Adriana Hermis; Sajad Shehab; Phillip J Newton; Sara Lal; Patricia M Davidson
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

Review 2.  Peripheral arterial disease, type 2 diabetes and postprandial lipidaemia: Is there a link?

Authors:  Pedro Valdivielso; José Ramírez-Bollero; Carmen Pérez-López
Journal:  World J Diabetes       Date:  2014-10-15

3.  [Criteria for referral between levels of care of patients with peripheral vascular disease. SEMFYC-SEACV consensus document].

Authors:  Santiago Díaz Sánchez; Nuria Piquer Farrés; Eva Fuentes Camps; Sergi Bellmunt Montoya; Ignacio Sánchez Nevárez; Fidel Fernández Quesada
Journal:  Aten Primaria       Date:  2012-07-21       Impact factor: 1.137

4.  Screening for coronary artery disease in patients with type 2 diabetes mellitus: An evidence-based review.

Authors:  Sandeep Chopra; Soumia Peter
Journal:  Indian J Endocrinol Metab       Date:  2012-01

5.  Contribution of the ankle-brachial index to improve the prediction of coronary risk: The ARTPER cohort.

Authors:  Rosa Forés; Maria Teresa Alzamora; Guillem Pera; José Miguel Baena-Díez; Xavier Mundet-Tuduri; Pere Torán
Journal:  PLoS One       Date:  2018-01-16       Impact factor: 3.240

6.  Frequency of lower extremity artery disease in type 2 diabetic patients using pulse oximetry and the ankle-brachial index.

Authors:  Mosquera-Fernández Abián; Balboa-Barreiro Vanesa; Bellido-Guerrero Diego; González-Sagrado Manuel; Vale-Carrodeguas Maria; Veiga-Seijo Raquel; González-Martín Cristina
Journal:  Int J Med Sci       Date:  2021-05-27       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.